O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1

FEBS Letters

Volumn 583, Issue 3, 2009, Pages 512-520

  Lim, Kihong ^a   Chang, Hyo Ihl ^a  

^a Korea University   (South Korea)

Author keywords

O GlcNAc; Oct1; Sp1; U2 snRNA

Indexed keywords

N ACETYLGLUCOSAMINE; OCTAMER TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR SP1;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION;

ACETYLGLUCOSAMINE; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; ORGANIC CATION TRANSPORTER 1; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, SMALL NUCLEAR; SERINE; SP1 TRANSCRIPTION FACTOR; THREONINE; TRANSCRIPTION, GENETIC;

EID: 58649098191     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.12.007     Document Type: Article

References (25)

1. Zachara N.E., and Hart G.W. Cell signaling, the essential role of O-GlcNAc!. Biochim. Biophys. Acta. 1761 (2006) 599-617
2. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., and Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115 (2003) 715-725
3. Lim K.H., and Chang H.I. O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1. FEBS Lett. 580 (2006) 4645-4652
4. Zachara N.E., O'Donnell N., Cheung W.D., Mercer J.J., Marth J.D., and Hart G.W. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. J. Biol. Chem. 279 (2004) 30133-30142
5. Forsythe M.E., Love D.C., Lazarus B.D., Kim E.J., Prinz W.A., Ashwell G., Krause M.W., and Hanover J.A. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc. Natl. Acad. Sci. USA 103 (2006) 11952-11957
6. Vosseller K., Wells L., Lane M.D., and Hart G.W. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 99 (2002) 5313-5318
7. Yang X., Su K., Roos M.D., Chang Q., and Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc. Natl. Acad. Sci. USA 98 (2001) 6611-6616
8. Bowe D.B., Sadlonova A., Toleman C.A., Novak Z., Hu Y., Huang P., Mukherjee S., Whitsett T., Frost A.R., Paterson A.J., and Kudlow J.E. O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors. Mol. Cell. Biol. 26 (2006) 8539-8550
9. Yang X., Zhang F., and Kudlow J.E. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression. Cell 110 (2002) 69-80
10. Jackson S.P., and Tjian R. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell 55 (1988) 125-133
11. Han I., and Kudlow J.E. Reduced O-glycosylation of Sp1 is associated with increased proteasomal susceptibility. Mol. Cell. Biol. 17 (1997) 2550-2558
12. Dauphinee S.M., Ma M., and Too C.K.L. Role of O-linked β-N-acetylglucosamine modification in the subcellular distribution of Alpha4 phosphoprotein and Sp1 in rat lymphoma cells. J. Cell. Biochem. 96 (2005) 579-588
13. Roos M.D., Su K., Baker J.R., and Kudlow J.E. O-glycosylation of a Sp1-derived peptide blocks known Sp1 protein interactions. Mol. Cell. Biol. 17 (1997) 6472-6480
14. Strom A.C., Forsberg M., Lillhager P., and Westin G. The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression. Nucleic Acids. Res. 24 (1996) 1981-1986
15. Percipalle P., Fomproix N., Cavellan E., Viot R., Reimer G., Kruger T., Thyberg J., Scheer U., Grummt I., and Farrants A.O. The chromatin remodeling complex WSTF-SNF2h interacts with nuclear myosin 1 and has a role in RNA polymerase I transcription. EMBO Rep. 7 (2006) 525-530
16. Janson L., and Pettersson U. Cooperative interaction between transcription factors Sp1 and OTF-1. Proc. Natl. Acad. Sci. USA 87 (1990) 4732-4736
17. Kadonaga J.T., Courey A.J., Ladika J., and Tjian R. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science 242 (1988) 1566-1570
18. Wells L., Vosseller K., Cole R.N., Cronshow J.M., Matunis M.J., and Hart G.W. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol. Cell. Proteomics 1 (2002) 791-804
19. Chou T.-Y., Hart G.W., and Dang C.V. c-Myc is glycosylated at threonine58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270 (1995) 18961-18965
20. Comer F.I., and Hart G.W. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry 40 (2001) 7845-7852
21. Jackson S.P., MacDonald J.J., Lees-Miller S., and Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63 (1990) 155-165
22. Tang Q.Q., Jiang M.S., and Lane M.D. Repressive effect of Sp1 on the C/EBPα gene promoter: role in adipocyte differentiation. Mol. Cell. Biol. 19 (1999) 4855-4865
23. Gewinner C., Hart G., Zachara N., Cole R., Beisenherz-Huss C., and Groner B. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J. Biol. Chem. 279 (2004) 3563-3572
24. Goldberg H.J., Whiteside C.I., Hart G.W., and Fantus I.G. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology 147 (2006) 222-231
25. James L.R., Tang D., Ingram A., Ly H., Thai K., Cai L., and Scholey J.W. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation. Diabetes 51 (2002) 1146-1156